Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.90 +0.01 (+1.41%)
As of: Oct 1, 2026 · 2:32 PM EDT

Alaunos Therapeutics (TCRT) Short term Debt (2021 - 2023)

Updated

Alaunos Therapeutics' Short term Debt came in at $10.99 million for Q1 2023, down 21.5% from $13.99 million a year earlier and down 34.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Short term Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Alaunos Therapeutics' Short term Debt was $16.77 million, up 113.1% from FY2021.

  • Going back by year, Short term Debt was $7.87 million in FY2021.
  • The Q1 2023 figure represents the lowest quarterly Short term Debt since Q4 2021.
  • Business Quant data shows TCRT's Short term Debt at $16.77 million (Q4 2022), $22.67 million (Q3 2022) and $20.05 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alaunos Therapeutics 2.19 Mn -1.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 10.99 Mn
Dec 31, 2022 16.77 Mn
Sep 30, 2022 22.67 Mn
Jun 30, 2022 20.05 Mn
Mar 31, 2022 13.99 Mn
Dec 31, 2021 7.87 Mn
Sep 30, 2021 12.04 Mn
API Access

Alaunos Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TCRT&period=max&api_key=YOUR_API_KEY